Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

BACKGROUND Toxic epidermal necrolysis (TEN) is a very rare but extremely severe drug reaction characterized by widespread apoptosis of epidermis with extensive blisters. We previously found drug-specific cytotoxic CD8 T lymphocytes in the blisters of a single patient. OBJECTIVE To confirm the role of drug specific cytotoxic lymphocytes in a larger series, to test the cytotoxicity on keratinocytes, and to look for cross-reactivity between chemically related drugs. METHODS The phenotype of lymphocytes present in the blister fluids of 6 patients with TEN was analyzed by flow cytometry. Cytotoxic functions were tested by chromium release assay on a variety of target cells (autologous or MHC class I-matched EBV-transformed lymphocytes, autologous keratinocytes) after nonspecific (CD3 monoclonal antibody) or specific (suspected and potentially cross-reactive drugs) activation. RESULTS Blister lymphocytes were CD8 + HLA-DR + CLA + CD56 + . In all 6 cases, they were cytotoxic after nonspecific activation. A drug-specific cytotoxicity was observed in 4 cases (3 related to cotrimoxazole and 1 to carbamazepine) toward lymphocytes. Blister cells also killed IFN-gamma-activated autologous keratinocytes in the presence of drug in the 2 patients tested. Blister cells showed a strong immunoreactivity for granzyme B, and cytotoxicity was abolished by EGTA, but not by anti-Fas/CD95, suggesting perforin/granzyme-mediated killing. By using several sulfonamides for testing the specificity of the drug T-cell receptor interaction, we observed cross-reactivity only between 4 structurally closely related medications. CONCLUSION These results strongly suggest that drug-specific, MHC class I-restricted, perforin/granzyme-mediated cytotoxicity probably has a primary role in TEN.

[1]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[2]  Pichler,et al.  T‐cell‐mediated cytotoxicity against keratinocytes in sulfamethoxazol‐induced skin reaction , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  H. Merk,et al.  CD8+ dermal T cells from a sulphamethoxazole‐induced bullous exanthem proliferate in response to drug‐modified liver microsomes , 1995, The British journal of dermatology.

[4]  W. Pichler,et al.  Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. , 1997, The Journal of clinical investigation.

[5]  J. Roujeau,et al.  Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis , 1996, The British journal of dermatology.

[6]  D. Speiser,et al.  Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression1 , 2000, The Journal of Immunology.

[7]  C. Brander,et al.  Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. , 1995, Journal of immunology.

[8]  A. Tamburro,et al.  Conformational modeling of elastin tetrapeptide Boc-Gly-Leu-Gly-Gly-NMe by molecular dynamics simulations with improvements to the thermalization procedure. , 1995, Journal of biomolecular structure & dynamics.

[9]  K. Yoshikawa,et al.  Induction of T‐cell‐mediated skin disease specific for antigen transgenically expressed in keratinocytes , 2003, European journal of immunology.

[10]  M. Pirmohamed,et al.  Recognition of Sulfamethoxazole and Its Reactive Metabolites by Drug-Specific CD4+ T Cells from Allergic Individuals1 , 2000, The Journal of Immunology.

[11]  K. Frutig,et al.  T Cells Isolated from Positive Epicutaneous Test Reactions to Amoxicillin and Ceftriaxone are Drug Specific and Cytotoxic , 2000 .

[12]  Martine Bagot,et al.  Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. , 2002, The Journal of investigative dermatology.

[13]  O. Correia,et al.  Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. , 1993, Archives of dermatology.

[14]  A. Limat,et al.  Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles. , 1986, The Journal of investigative dermatology.

[15]  B. Sugden,et al.  Clonal transformation of adult human leukocytes by Epstein-Barr virus , 1977, Journal of virology.

[16]  D. Becker.  Toxic epidermal necrolysis , 1969, The Lancet.

[17]  A. Lyell.  Toxic epidermal necrolysis (the scalded skin syndrome): A reappraisal , 1979, The British journal of dermatology.

[18]  M. Pirmohamed,et al.  Characterization of drug-specific T cells in lamotrigine hypersensitivity. , 2003, The Journal of allergy and clinical immunology.

[19]  L. Naldi,et al.  Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis , 2001, AIDS.

[20]  R. Stern,et al.  Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.

[21]  A. Romano,et al.  Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. , 2002, The Journal of allergy and clinical immunology.